- Home
- NEWT vs CYRX Comparison
NEWT vs CYRX Comparison
Compare NEWT & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NEWT | CYRX |
|---|---|---|
| Founded | 1998 | 1999 |
| Country | United States | United States |
| Employees | N/A | 1100 |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 395.5M | 419.3M |
| IPO Year | N/A | 2008 |
Fundamental Metrics
Financial Performance| Metric | NEWT | CYRX |
|---|---|---|
| Price | $12.73 | $10.07 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 9 |
| Target Price | ★ $15.33 | $12.94 |
| AVG Volume (30 Days) | 225.8K | ★ 404.5K |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | ★ 6.05% | N/A |
| EPS Growth | N/A | ★ 156.22 |
| EPS | N/A | ★ 1.40 |
| Revenue | N/A | ★ $176,177,000.00 |
| Revenue This Year | N/A | $11.06 |
| Revenue Next Year | $12.45 | $8.45 |
| P/E Ratio | ★ $5.99 | $7.11 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.51 | $5.21 |
| 52 Week High | $14.91 | $11.45 |
Technical Indicators
Market Signals| Indicator | NEWT | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 64.88 | 71.38 |
| Support Level | $12.64 | $9.18 |
| Resistance Level | $14.91 | $10.23 |
| Average True Range (ATR) | 0.38 | 0.42 |
| MACD | 0.23 | 0.18 |
| Stochastic Oscillator | 97.93 | 90.10 |
Price Performance
Historical ComparisonAbout NEWT NewtekOne Inc.
NewtekOne Inc is a financial holding company engaged in providing financial solutions to its Client Base. It is an internally managed non-diversified closed-end management investment company. It has four reportable segments Banking, Alternative Lending, Technology, NSBF, and Payments.
About CYRX CryoPort Inc.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.